CHICAGO (AP) — CHICAGO (AP) — Exelon Corp. (EXC) on Wednesday reported fourth-quarter earnings of $647 million. The results exceeded Wall Street expectations. The average estimate of five analysts ...

SaveHealth provides an overview of Alzheimer's disease, including treatment and coping mechanisms for those with the disease and caregivers.

Xarelto is a brand name of the drug rivaroxaban. Medicare covers the cost of prescription medications, including Xarelto, under certain conditions. A person must be enrolled in a Medicare Part D ...

Barclays analyst Nicholas Campanella maintained a Buy rating on Exelon (EXC – Research Report) today and set a price target of $42.00. The company’s shares closed yesterday at $40.44.

Some of China’s senior doctors are raising concern over the quality of domestic generic medicines that have largely replaced western brand-name drugs at hospitals, amid a rare public backlash ...